81 / 100

Kunal Mohan Gokhale | Metal-Organic Frameworks | Best Researcher Award

Dr. Kunal Mohan Gokhale, Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, India.

Dr. Kunal Mohan GokhaleĀ šŸŽ“Ā is an accomplished Assistant Professor at the Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, NMIMS Mumbai, with over 17 years of teaching experience. He specializes in organic and medicinal chemistry, nanomaterials, and metal-organic frameworks, contributing significantly to pharmaceutical sciences. Dr. Gokhale earned his Ph.D. in Tech (2021) from ICT Mumbai, focusing on anti-TB molecule design. He holds 19 research publications and an Indian patent, reflecting his commitment to innovation in pharmacy and medicinal chemistry. He is fluent in English, Marathi, and Sanskrit, exemplifying his cultural and academic versatility.Ā šŸŒŸ

Publivation Profiles

Orcid
Scopus
Googlescholar

Education and Experience

šŸ“˜Ā Education:

  • Ph.D. (Tech), ICT, Mumbai (2021) ā€“ Anti-TB Molecule Design
  • M. Pharm Sci., UICT, Mumbai (2006) ā€“ Synthesis of Bioactive Molecules
  • B. Pharm Sci., K.M. Kundnani College of Pharmacy, Mumbai (2004)

šŸ¢Ā Experience:

  • Assistant Professor, NMIMS Mumbai (Since March 2023)
  • Assistant Professor, Dr. L.H. Hiranandani College of Pharmacy, Ulhasnagar (2006ā€“2023)
  • Guided 15 M.Pharm students and is an approved Ph.D. guide at the University of Mumbai.

Suitability summary for best researcher Award

Dr. Kunal Mohan Gokhale, an accomplished academician and researcher with overĀ 17 years of teaching and research experience, is a highly deserving candidate for the prestigiousĀ Best Researcher Award. His groundbreaking contributions to pharmacy and medicinal chemistry, particularly his innovative work inĀ metal-organic frameworks, nanomaterials, antibiofilm activity, and process chemistry, have garnered significant recognition. Dr. Gokhale’s career is marked by exceptional achievements, including impactful research publications, mentoring of postgraduate and doctoral students, and a recently granted patent for a novel synthesis process.

Professional Development

Dr. Kunal Gokhale has demonstrated consistent professional growth, contributing to pharmacy and medicinal chemistry research for over 17 years.Ā šŸ§ŖĀ His areas of expertise include metal-organic frameworks, nanomaterials, and antibiofilm activity. With 19 research publications and 15 M.Pharm students guided under his mentorship, Dr. Gokhaleā€™s work bridges academia and innovation. His patent on the heterocoupling synthesis of 3-Phenyl-4H-chromen-4-one exemplifies his pioneering approach in process chemistry. Additionally, his role as an approved guide for postgraduate and doctoral research highlights his leadership in pharmaceutical education and research.Ā šŸŒŸ

Research Focus

Dr. Kunal Gokhaleā€™s research focuses on cutting-edge areas in pharmaceutical sciences.Ā šŸ”¬Ā He specializes inĀ metal-organic frameworks,Ā nanomaterials, and theirĀ antibiofilm activityĀ for medical applications. His expertise extends to the development of innovative routes for synthesizing bioactive molecules, as demonstrated by his Ph.D. research on anti-TB compounds. His contributions in process chemistry and nanotechnology aim to advance drug discovery and material science for healthcare innovations.Ā šŸŒĀ Dr. Gokhaleā€™s interdisciplinary approach underscores his dedication to improving therapeutic solutions through research.

Publication Top Noted

  • Mechanisms of bacterial acetohydroxyacid synthase (AHAS) and specific inhibitors ofĀ Mycobacterium tuberculosisĀ AHAS as potential drug candidates against tuberculosisĀ ā€“Ā Current Drug TargetsĀ (2015),Ā Cited by: 25Ā šŸ§Ŗ
  • Green chemistry: Need of the hourĀ ā€“Ā Indian Journal of Pharmaceutical Education and ResearchĀ (2011),Ā Cited by: 15Ā šŸŒ±
  • Synthesis of Di and Trisubstituted Oxazoles in Nonionic Liquid Under Catalyst Free ConditionsĀ ā€“Ā Int. J. Pharm. Phytopharm. Res.Ā (2012),Ā Cited by: 11Ā āš—ļø
  • Novel peptidomimetic peptide deformylase (PDF) inhibitors ofĀ Mycobacterium tuberculosisĀ ā€“Ā Chemical Biology & Drug DesignĀ (2021),Ā Cited by: 10Ā šŸ§¬
  • Role of glycogen synthase kinase (GSK-3) in type-2 diabetes and GSK-3 inhibitors as potential anti-diabeticsĀ ā€“Ā Int. J. Pharm. Phytopharm. Res.Ā (2014),Ā Cited by: 9Ā šŸ©ŗ
  • Silica chloride (SiOā‚‚-Cl) catalyzed one-pot synthesis of 2,3-disubstituted-thiazolidin-4-oneĀ ā€“Ā Synthetic CommunicationsĀ (2020),Ā Cited by: 7Ā šŸ§Ŗ
  • New method for synthesis of 3-(4-hydroxy-3-methoxyphenyl) prop-2-enoic acid and 1-feruloyl-Ī²-D-glucoseĀ ā€“Ā Int. J. Pharm. Phytopharm. Res.Ā (2011),Ā Cited by: 5Ā šŸŒæ

 

Kunal Mohan Gokhale | Metal-Organic Frameworks | Best Researcher Award

You May Also Like